Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-264-5 | CAS number: 3049-71-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- study is not fully compliant with current guidelines.
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 967
- Report date:
- 1967
- Reference Type:
- other: summary report
- Title:
- Unnamed
- Year:
- 1 967
- Report date:
- 1967
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- 2,9-bis(3,5-dimethylphenyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone
- EC Number:
- 225-590-9
- EC Name:
- 2,9-bis(3,5-dimethylphenyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone
- Cas Number:
- 4948-15-6
- Molecular formula:
- C40H26N2O4
- IUPAC Name:
- 2,9-bis(3,5-dimethylphenyl)isoquino[4',5',6':6,5,10]anthra[2,1,9-def]isoquinoline-1,3,8,10(2H,9H)-tetrone
- Details on test material:
- Test materials used in this dossier are all considered to fall under the definition of nano-materials according to the European Commission Recommendation 2011/696/EU as the synthesis and manufacturing of this pigment always yields particulate material with a fine particle size distribution.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: albino
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Mean weight at study initiation: 130 g (males) and 121 g (females)
- Housing: Makrolon cages on wood shavings, 5 animals per cage
- Diet (e.g. ad libitum): ALTROMIN R, manufactured by Altromin GmbH in Lage/Lippe
- Water (e.g. ad libitum): tap water, ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 - 25
- Humidity (%): 35 - 60
- Air changes (per hr): partially air-conditioned animal rooms
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- DIET PREPARATION
- Rate of preparation of diet (frequency): pelleted feed was freshly prepared at 7-8-day intervals
- Mixing appropriate amounts with (Type of food): ALTROMIN R, manufactured by Altromin GmbH in Lage/Lippe - Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- 90 days
- Frequency of treatment:
- daily
Doses / concentrationsopen allclose all
- Dose / conc.:
- 10 000 ppm
- Remarks:
- 1% in feed
- Dose / conc.:
- 50 000 ppm
- Remarks:
- 5% in feed
- No. of animals per sex per dose:
- 15
- Control animals:
- yes, plain diet
Examinations
- Observations and examinations performed and frequency:
- Each rat was monitored daily to determine its behaviour and general state of health. The body weight of each animal was determined once a week and the food consumption at 7-day intervals.
Before the start and at the end of the trial haematological and urine investigations were carried out in 10 male and 10 female rats from each group. The haematological investigation included determination of the haemoglobin content, number of red and white blood cells as well as the evaluation of the differential blood count and the possible presence of Heinz bodies. The urine investigation covered appearance, colour, protein and sediment. - Sacrifice and pathology:
- At the end of the trial all the animals were killed and autopsied and the organs were subjected to histological examination.
Macro- and microscopic examination of the organs heart, lung, liver, kidney, adrenal glands, spleen, cerebrum, cerebellum, testes and ovaries, pancreas, pituitary, thyroid gland, stomach and small intestine.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- All the animals displayed normal behaviour during the trial and no signs of a toxic effect were observed which would have been caused by the pigment. The pigment was excreted via the faeces.
- Mortality:
- mortality observed, non-treatment-related
- Description (incidence):
- There were isolated spontaneous deaths during the trial. One rat (animal no. 304) from group 1 (5%) died after 33 trial days and a further rat (animal no. 337) after 73 trial days. One rat (animal no. 362) from group III (control) died after 23 trial days. The rats died of pneumonia. No connection between the substance administered and the deaths could be detected.
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- The weight gains of the male and female rats from groups I (5%) and II (1%) were normal and corresponded to those of the control animals.
- Food consumption and compound intake (if feeding study):
- no effects observed
- Description (incidence and severity):
- The food consumption of the experimental animals was the same as that of the control rats.
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Description (incidence and severity):
- The haematological investigations showed no pathological findings even at the end of the trial.
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- no effects observed
- Description (incidence and severity):
- The urine investigations showed no pathological findings at the end of the trial. The male rats showed slight protein excretion at the end of the trial which is a physiological feature of adult male rats.
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Description (incidence and severity):
- The organ weight gains of the male and female rats from groups I (5%) and II (1%) were normal and corresponded to those of the control animals.
- Gross pathological findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Macroscopic examination of the organs of rats that had received the pigment in their feed in a 90-day trial revealed no pathological organ damage. Inflammatory lung changes were detected at autopsy in experimental animals no. 304 and 337. Animal no. 322 displayed a liver change for which no reason could be found. The controls no. 360 and 362 also had inflammatory lung processes arid the liver of no. 400 was interspersed with yellowish spots the size of a pinhead. The striking feature of no. 413 was very marked liver lobule patterning.
- Neuropathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Histological examination of the organs of rats that had received the pigment in their feed in a 90-day trial revealed no pathological organ damage. The lymphocytic infiltrates frequently observed in the heart, liver, kidneys and intestine are a manifestation of quiescent infections. The perifollicular hyperplasia in the spleen should also be assessed as a non-specific defense reaction of this type. The histo-lymphocytic granulomas found in the liver may be a manifestation of a pre-existing infection, most probably salmonellosis. The lung changes found are characteristic of rat-specific pneumonia. In many of the animals there was impaired spermiogenesis in the form of varying degrees of desquamation of prespermatid cells. The striking frequency in the control group (11 cases) and in the group that received 5% test material (9 cases) and the only isolated occurrence in the group that was given 1% test item (2 cases) indicates that these changes are not attributable to the test substance. In addition, the changes in the brain in the form of meningoencephalitis occasionally observed developed in some cases with foci of glial proliferation independent of the study. These brain changes are diagnosed in rats more frequently than random findings, without causing clinical symptoms. The thyroid changes in the form of interfollicular solidification, associated with formation of follicles to varying degrees, occurred in both the control and the experimental animals.
In summary, it can be stated that no obvious study-related changes were observed. The test item therefore caused no organ-damaging effects in rats in the dosages given and over the selected period of administration.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 50 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: no adverse effects were reported
Target system / organ toxicity
- Critical effects observed:
- no
Applicant's summary and conclusion
- Conclusions:
- In summary, it can be stated that no obvious study-related changes were observed. The test substance therefore caused no organ-damaging effects in rats in the dosages given and over the selected period of administration.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
За да гарантираме, че се възползвате максимално от функциите на нашия уебсайт, сме въвели „бисквитки“.